Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials

BACKGROUND: Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of psoriasis-related functionality and health-related quality...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shikiar, Richard, Bresnahan, Brian W, Stone, Stephen P, Thompson, Christine, Koo, John, Revicki, Dennis A
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2003
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC269993/
https://ncbi.nlm.nih.gov/pubmed/14613569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-1-53
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars